| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.031 | 60.956 | 28.697 | 36.266 | 196.651 | 3.768 | 7.317 | 8.832 | 6.118 | 9.597 |
| Total Income - EUR | 58.031 | 60.956 | 28.697 | 53.754 | 197.664 | 3.773 | 7.317 | 8.832 | 6.118 | 9.597 |
| Total Expenses - EUR | 27.357 | 27.911 | 21.458 | 6.416 | 32.032 | 23.364 | 21.643 | 21.978 | 13.492 | 13.506 |
| Gross Profit/Loss - EUR | 30.674 | 33.046 | 7.238 | 47.338 | 165.632 | -19.592 | -14.326 | -13.146 | -7.374 | -3.909 |
| Net Profit/Loss - EUR | 28.933 | 31.217 | 5.912 | 45.726 | 163.655 | -19.628 | -14.541 | -13.366 | -7.435 | -3.909 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Algesis Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.236 | 10.967 | 344 | 61.617 | 45.275 | 29.611 | 14.479 | 1 | 1 | 1 |
| Current Assets | 20.964 | 32.596 | 27.144 | 17.414 | 146.515 | 6.814 | 1.466 | 1.555 | 899 | 449 |
| Inventories | 0 | 0 | 165 | 162 | 158 | 155 | 152 | 152 | 152 | 151 |
| Receivables | 0 | 842 | 0 | 0 | 107.007 | 289 | 353 | 1.169 | 695 | 0 |
| Cash | 20.964 | 31.754 | 26.979 | 17.253 | 39.350 | 6.370 | 962 | 233 | 52 | 298 |
| Shareholders Funds | 28.978 | 31.270 | 5.964 | 45.777 | 163.706 | 15.323 | 443 | -12.922 | -20.318 | -24.113 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.458 | 12.557 | 21.542 | 33.279 | 28.091 | 21.109 | 15.514 | 14.490 | 21.726 | 24.568 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Algesis Med Srl